Comment on: Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in patients with chronic pain

Can J Anaesth. 2021 Nov;68(11):1707-1708. doi: 10.1007/s12630-021-02078-z. Epub 2021 Aug 4.

Authors

Luis Vitetta^{1

2}, Jason F Sikali^{3

4}

Affiliations

¹ Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. luis.vitetta@sydney.edu.au.
² Research Department, Medlab Clinical, Sydney, Australia. luis.vitetta@sydney.edu.au.
³ Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
⁴ Research Department, Medlab Clinical, Sydney, Australia.

PMID: 34350557
DOI: 10.1007/s12630-021-02078-z

No abstract available

Keywords: cannabinoids; gut dysbiosis; longitudinal studies; pain.

Publication types

Letter
Comment

MeSH terms

Chronic Pain* / drug therapy
Humans
Medical Marijuana*
Patient Reported Outcome Measures
Prospective Studies
Quality of Life

Substances

Medical Marijuana